A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis

scientific article published on 01 November 1999

A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0016-5085(99)70403-8
P698PubMed publication ID10535881

P2093author name stringA Sharma
M M Kaplan
C Schmid
D Provenzale
G Dickstein
A McKusick
P2860cites workA multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupQ28243457
Characterisation of patients with a complete biochemical response to ursodeoxycholic acidQ34408204
Methotrexate-induced liver cirrhosis. A follow-up.Q42219550
A prospective trial of colchicine for primary biliary cirrhosisQ42659809
Prognosis in primary biliary cirrhosis: model for decision makingQ46316848
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.Q54118475
Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.Q55052049
Methotrexate for primary biliary cirrhosisQ68100745
Evaluation of colchicine therapy in primary biliary cirrhosisQ68139571
Primary Biliary Cirrhosis Treated with Low-Dose Oral Pulse MethotrexateQ68481563
A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary reportQ69401293
Efficacy of liver transplantation in patients with primary biliary cirrhosisQ69507347
New strategies needed for treatment of primary biliary cirrhosis?Q70542361
Time course of histological progression in primary biliary cirrhosisQ70869710
Primary biliary cirrhosisQ71742524
Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosisQ72036049
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acidQ72189521
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisQ72401649
Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatmentQ73316077
Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progressionQ74645177
Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiolQ78039881
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectprimary biliary cholangitisQ1072420
(S)-(−)-colchicineQ326224
methotrexateQ422232
P304page(s)1173-1180
P577publication date1999-11-01
P1433published inGastroenterologyQ4039279
P1476titleA prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
P478volume117

Reverse relations

cites work (P2860)
Q44825279A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results
Q36116022Advances in pharmacotherapy for primary biliary cirrhosis
Q34269621Autoimmune liver disease. Current standards, future directions.
Q33881922Bile formation and secretion
Q37182934Clinical features and management of primary biliary cirrhosis.
Q24186361Colchicine for prevention of cardiovascular events
Q24247122Colchicine for primary biliary cirrhosis
Q24248630Colchicine for primary biliary cirrhosis
Q34408950Current status of therapy in autoimmune liver disease
Q34687676Drug therapy of primary biliary diseases: classical and modern strategies.
Q36502610Fenofibrate for patients with asymptomatic primary biliary cirrhosis
Q24235442Methotrexate for primary biliary cirrhosis
Q24246659Methotrexate for primary biliary cirrhosis
Q34904107Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience
Q34354186Options for treatment of primary biliary cirrhosis
Q38738566Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Q26799419Primary biliary cirrhosis: From bench to bedside
Q35573929Primary biliary cirrhosis: specific treatment

Search more.